Rubius Therapeutics Raises $100 Million in Crossover Financing Post author:Sam Post published:February 28, 2018 Post category:BioPharma Rubius Therapeutics has closed on an oversubscribed $100 million crossover financing. Source: BioSpace You Might Also Like When It Rains, It Pours: Bay Area's OncoMed Tanks Again as Lung Cancer Med Fails Phase II, Discontinues Phase I Study April 16, 2017 Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub October 8, 2017 Seattle Genetics Gains Another FDA Approval March 20, 2018
When It Rains, It Pours: Bay Area's OncoMed Tanks Again as Lung Cancer Med Fails Phase II, Discontinues Phase I Study April 16, 2017
